Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Zhou%2C+Yunjiao%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Zhou%2C+Yunjiao%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Zhou%2C+Yunjiao%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (23)
1
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants
enthalten in:
bioRxiv.org
| 2024
von
Wu, J.
|
Chen, Z.
|
Gao, Y.
| +19
Wird geladen...
2
Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants
enthalten in:
Cell reports
| 2023
von
Wu, J.
|
Chen, Z.
|
Gao, Y.
| +19
UpdateOf: bioRxiv. 2022 Dec 13;:. - PMID 36561175
Wird geladen...
3
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2 : Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies
enthalten in:
Journal of medical virology
| 2023
von
Li, S.
|
Wu, J.
|
Jiang, W.
| +22
Wird geladen...
4
Characterization of cross‐reactive monoclonal antibodies against SARS‐CoV‐1 and SARS‐CoV‐2 : Implication for rational design and development of pan‐sarbecovirus vaccines and neutralizing antibodies
enthalten in:
Journal of Medical Virology
| 2023
von
Li, S.
|
Wu, J.
|
Jiang, W.
| +22
Wird geladen...
5
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants
enthalten in:
bioRxiv : the preprint server for biology
| 2022
von
Wu, J.
|
Chen, Z.
|
Gao, Y.
| +19
UpdateIn: Cell Rep. 2023 May 3;42(5):112503. - PMID 37178120
Wird geladen...
6
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
enthalten in:
Protein & cell
| 2022
von
Liu, Z.
|
Xu, W.
|
Chen, Z.
| +25
Wird geladen...
7
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
enthalten in:
Cell research
| 2022
von
Wang, L.
|
Fu, W.
|
Bao, L.
| +11
Wird geladen...
8
NEUTRALIZING ANTIBODY HAVING NO ADE EFFECT FOR SARS-COV-2
enthalten in:
Europäisches Patentamt
| 2022
von
WANG QIAO
|
LU LU
|
ZHOU YUNJIAO
| +1
Wird geladen...
9
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
enthalten in:
Nature
| 2022
von
Wang, K.
|
Jia, Z.
|
Bao, L.
| +31
CommentIn: Signal Transduct Target Ther. 2022 Apr 5;7(1):115. - PMID 35383164
Wird geladen...
10
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
enthalten in:
bioRxiv.org
| 2021
von
Li, F.
|
Han, M.
|
Dai, P.
| +24
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
23
Aufsätze
23
E-Artikel
23
E-Ressourcen
Zeitschriftentitel
3
Aging clinical and experimental research
3
Protein & cell
3
bioRxiv.org
2
Cell reports
1
Antimicrobial agents and chemotherapy
1
Cell research
1
European journal of gastroenterology & hepatology
1
Europäisches Patentamt
1
Journal of Medical Virology
1
Journal of medical virology
1
Nature
1
Nature communications
1
PLoS biology
1
Signal transduction and targeted therapy
1
The Journal of infection
1
bioRxiv : the preprint server for biology
Alle anzeigen ...
weniger ...
Thema
12
Journal Article
9
Research Support, Non-U.S. Gov't
7
Antibodies, Neutralizing
7
Antibodies, Viral
7
SARS-CoV-2
6
Spike Glycoprotein, Coronavirus
6
spike protein, SARS-CoV-2
5
COVID-19
4
Antibodies, Monoclonal
4
Meta-analysis
3
Broadly Neutralizing Antibodies
3
Death
3
Epitopes
3
Review
3
Severe acute respiratory syndrome coronavirus 2
3
XG014
3
antibody-dependent cell-cell fusion
3
neutralizing antibody
3
receptor-binding domain
2
Angiotensin-Converting Enzyme 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
3
2023
5
2022
9
2021
5
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...